Adient | 10-K: FY2025 Revenue Beats Estimate at USD 14.54 B

Revenue: As of FY2025, the actual value is USD 14.54 B, beating the estimate of USD 14.46 B.

EPS: As of FY2025, the actual value is USD -3.39, missing the estimate of USD -2.8158.

EBIT: As of FY2025, the actual value is USD 115 M.

Americas Segment

• Net Sales: $6,856 million, a 1% increase from the previous year.
• Adjusted EBITDA: $402 million, a 7% increase from the previous year, driven by favorable commercial and supplier pricing adjustments, favorable operating performance, and higher production volumes.

EMEA Segment

• Net Sales: $4,773 million, a 5% decrease from the previous year, primarily due to lower production volumes and unfavorable product mix.
• Adjusted EBITDA: $124 million, a 20% decrease from the previous year, impacted by lower production volumes, unfavorable product mix, and higher operating costs.

Asia Segment

• Net Sales: $2,983 million, relatively flat compared to the previous year.
• Adjusted EBITDA: $440 million, relatively flat compared to the previous year, with favorable operating performance offset by unfavorable product mix and lower equity income.

Outlook / Guidance

Adient anticipates fiscal 2026 cash flows to be lower than fiscal 2025 due to reduced profitability from lower production volumes, higher capital spending for growth initiatives, non-recurring tax settlements, and an acceleration in the timing of commercial settlements in fiscal 2025.